ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
ARMI will attend the 2026 Military Health System Research Symposium (MHSRS), the Department of Defense’s premier scientific meeting focused on military medical research, healthcare innovation, and warfighter readiness.
ARMI will attend the ISSCR 2026 Annual Meeting, the premier global gathering for stem cell research and regenerative medicine, to connect with scientific leaders and explore emerging advances shaping the future of the field.
ARMI Chief Operating Officer Jennifer MacDonald will participate in a panel discussion at the Cell & Gene Therapy Summit 2026, exploring the scientific, manufacturing, regulatory, and commercialization challenges involved in bringing advanced therapies to patients.
ARMI will attend BIO 2026 to connect with biotechnology leaders, explore partnership opportunities, and engage in discussions shaping the future of advanced biomanufacturing and regenerative medicine.
Meeting in the Millyard 2027 (MITM27) marks the 10-year anniversary of ARMI | BioFabUSA’s flagship convening bringing together leaders across biomanufacturing, regenerative medicine, healthcare, manufacturing, workforce development, government, and industry to help shape the next decade of bioindustrial capability.
The ReGen Valley Community Update highlights regional progress in regenerative medicine and biomanufacturing, bringing together industry, education, workforce, and community leaders to showcase how collaboration is building the infrastructure needed to support the bioeconomy.
Join BioFabUSA on October 1, 2025, for our Innovator Spotlight webinar featuring Cook Myosite, IIAM, Likarda, New England Ovis, Pluristyx, and Spark Academy. This one-hour, members-only event highlights cutting-edge work in biofabrication and healthcare.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
